{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:05:34Z","timestamp":1780491934333,"version":"3.54.1"},"reference-count":22,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T00:00:00Z","timestamp":1494979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Numerous risk factors place palliative care patients at an increased risk of skin infections, dermatitis, and pressure sores. Furthermore, worsening of chronic skin disorders can be expected, as well as the development of treatment\u2010induced and malignancy\u2010related dermatoses. The objective of the present study was to investigate the prevalence and treatment of dermatological conditions in patients receiving hospital\u2010based palliative care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Two hundred seventy\u2010one palliative patients were enrolled. All assessments were conducted by dermatologists. Skin lesions were classified into seven categories: infections, skin tumors, dermatitis, chronic wounds, nail and hair disorders, pruritus, and other unclassified conditions. <jats:italic>Treatment modalities were classified as topical only or systemic<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, 1,267 dermatological conditions were recorded, 49\u00a0% of which were hospital\u2010acquired. All patients had at least one dermatological condition, and more than 50 different dermatological disorders were noted. The most common group of skin disorders was dermatitis (18.3\u00a0% of all dermatological conditions), followed by nail and hair disorders (17.5\u00a0%). Almost 16 % of dermatological conditions were treated systemically.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Dermatological conditions are a common and clinically significant problem for palliative patients. The inclusion of dermatologists in multidisciplinary palliative teams should prove helpful in the management of these patients.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ddg.13236","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T13:13:38Z","timestamp":1495026818000},"page":"621-627","source":"Crossref","is-referenced-by-count":4,"title":["Dermatological diseases in palliative care patients: a prospective study of 271 patients"],"prefix":"10.1111","volume":"15","author":[{"given":"Lenche","family":"Neloska","sequence":"first","affiliation":[{"name":"Gerontology Institute \u201c13 November\u201d  Skopje Republic of Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Damevska","sequence":"additional","affiliation":[{"name":"Department of Dermatology Medical Faculty, University \u201cSs Cyrilius and Methodius\u201d  Skopje Republic of Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andjelka","family":"Kuzmanova","sequence":"additional","affiliation":[{"name":"Gerontology Institute \u201c13 November\u201d  Skopje Republic of Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidija","family":"Pavleska","sequence":"additional","affiliation":[{"name":"Gerontology Institute \u201c13 November\u201d  Skopje Republic of Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milenko","family":"Kostov","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery Medical Faculty  Skopje Republic of Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biljana Petreska","family":"Zovic","sequence":"additional","affiliation":[{"name":"Gerontology Institute \u201c13 November\u201d  Skopje Republic of Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,5,17]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269216311435268"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00129334-200605000-00014"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2004.08.009"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2008.0009"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-032013-182406"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-684X-1-4"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(01)00264-0"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00129334-200605000-00014"},{"issue":"9","key":"e_1_2_8_10_1","first-page":"1010","article-title":"Pruritus in palliative care: Getting up to scratch","volume":"57","author":"Seccareccia D","year":"2011","journal-title":"Canadian Family Physician"},{"key":"e_1_2_8_11_1","first-page":"CD008320","article-title":"Pharmacological interventions for pruritus in adult palliative care patients","volume":"6","author":"Xander C","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1053\/ctrv.2001.0231"},{"key":"e_1_2_8_13_1","first-page":"84","volume-title":"Pruritus in advanced disease","author":"Krajnik M.","year":"2004"},{"key":"e_1_2_8_14_1","first-page":"107","volume-title":"Pruritus in advanced disease","author":"Krajnik M","year":"2004"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0b013e31823069cf"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.12968\/bjcn.2005.10.Sup1.17627"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASW.0000363502.84737.c8"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269216310376119"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.12968\/ijpn.2002.8.5.10368"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2009.12.021"},{"key":"e_1_2_8_21_1","first-page":"203","article-title":"Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer: part I. Conventional chemotherapeutic drugs","volume":"71","author":"Reyes\u2010Habito CM","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2010.09.022"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.17.2253"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fddg.13236","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ddg.13236","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T05:26:17Z","timestamp":1696310777000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ddg.13236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,17]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.1111\/ddg.13236"],"URL":"https:\/\/doi.org\/10.1111\/ddg.13236","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,17]]}}}